Laronde Stock

HealthTech

Looking to sell Laronde stock or options?

Founded: 2017Funding to Date: $471M

Laronde is the developer of eRNA-based therapeutics, designed to create more reliable and powerful medicines for global use. The company's unique Endless RNA (eRNA) can be programmed to produce a variety of proteins within the body. It is characterized by its persistence, non-immunogenic properties, repeat dosing capabilities, and formulation and delivery flexibility. This enables healthcare professionals and medical companies to develop innovative therapeutics that are poised to become essential future medicines.

Investors Include:

BlackRock, CPP Investments, Nextech Invest, Flagship Pioneering, Jameel Investment Management Co., Altitude Life Science Ventures, Federated Kaufmann Fund, Fidelity Management & Research, The Invus Group, Longevity Vision Fund, LifeSci Venture Partners, Quan Capital.

Looking to sell Laronde Stock or Options?

We have an even better solution: The Collective Exchange Fund

Get in touch and see if we can help you